Global Innovative Platforms Files 2024 10-K

TL;DR

GIP filed its 2024 10-K. Check financials.

AI Summary

Global Innovative Platforms Inc. filed its 10-K for the fiscal year ending September 30, 2024. The company, formerly known as Canning Street Corp, is incorporated in Delaware and operates in the real estate and construction sector. Its principal business address is 149 James Place, Maitland, FL 32751.

Why It Matters

This filing provides a comprehensive overview of Global Innovative Platforms Inc.'s financial performance and business operations for the fiscal year 2024, crucial for investors and stakeholders.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing header and does not contain specific financial performance data or forward-looking statements that would indicate a high risk.

Key Numbers

• 2024-09-30 — Fiscal Year End (Reporting period for the 10-K)
• 2024-12-30 — Filing Date (Date the 10-K was submitted)

Key Players & Entities

• Global Innovative Platforms Inc. (company) — Filer of the 10-K
• Canning Street Corp (company) — Former name of Global Innovative Platforms Inc.
• 149 James Place, Maitland, FL 32751 (location) — Business and mailing address
• 0001731122-24-002061 (filing_id) — Accession number for the filing

FAQ

Key Financial Figures

• $0.0001 — e Exchange Act: Common Stock, par value $0.0001 per share Indicate by check mark if t
• $30 — ted for heartworm annually at a cost of $30 to $50 per test, with most of these dog
• $50 — heartworm annually at a cost of $30 to $50 per test, with most of these dogs being

Filing Documents

• e6234_10-k.htm (10-K) — 777KB
• e6234_ex31-1.htm (EX-31.1) — 8KB
• e6234_ex32-1.htm (EX-32.1) — 4KB
• image_001.jpg (GRAPHIC) — 14KB
• image_0011.gif (GRAPHIC) — 1KB
• image_002.jpg (GRAPHIC) — 16KB
• image_003.jpg (GRAPHIC) — 151KB
• image_004.jpg (GRAPHIC) — 10KB
• image_005.jpg (GRAPHIC) — 13KB
• image_006.jpg (GRAPHIC) — 5KB
• image_007.jpg (GRAPHIC) — 9KB
• image_008.jpg (GRAPHIC) — 5KB
• image_009.jpg (GRAPHIC) — 9KB
• 0001731122-24-002061.txt ( ) — 3545KB
• cstc-20240930.xsd (EX-101.SCH) — 23KB
• cstc-20240930_cal.xml (EX-101.CAL) — 24KB
• cstc-20240930_def.xml (EX-101.DEF) — 57KB
• cstc-20240930_lab.xml (EX-101.LAB) — 198KB
• cstc-20240930_pre.xml (EX-101.PRE) — 164KB
• e6234_10-k_htm.xml (XML) — 221KB

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS of the Exchange Act, this Form 10-K contains forward-looking statements. The forward-looking statements are based on our current goals, plans, expectations, assumptions, estimates and predictions regarding the Company. When used in this Annual Report, the words "plan," "believes," "continues," "expects," "anticipates," "estimates," "intends," "should," "would," "could," or "may," and similar expressions are intended to identify forward looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or growths to be materially different from any future results, events or growths expressed or implied in this Annual Report. In this Annual Report on Form 10-K, "Global Innovative Platforms," the "Company,' we,' us,'' and our,'' refer to Global Innovative Platforms, Inc., unless the context otherwise requires. Unless otherwise indicated, the term fiscal year' refers to our fiscal year ending September 30 th . Unless otherwise indicated, the term common stock' refers to shares of the Company's common stock. TABLE OF CONTENTS GLOBAL INNOVATIVE PLATFORMS, INC. PART I PAGE ITEM 1

BUSINESS

BUSINESS 1 ITEM 1A

RISK FACTORS

RISK FACTORS 13 ITEM 1B UNRESOLVED STAFF COMMENTS 20 ITEM 1C CYBERSECURITY 20 ITEM 2

PROPERTIES

PROPERTIES 21 ITEM 3

LEGAL PROCEEDINGS

LEGAL PROCEEDINGS 21 ITEM 4 MINE SAFETY DISCLOSURES 21 PART II 21 ITEM 5 MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 21 ITEM 6 RESERVED 23 ITEM 7

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 23 ITEM 7A

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 35 ITEM 8

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 35 ITEM 9 CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 35 ITEM 9A

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 35 ITEM 9B OTHER INFORMATION 37 ITEM 9C DICLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 37 PART III 37 ITEM 10 DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 37 ITEM 11

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 41 ITEM 12

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 43 ITEM 13 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 44 ITEM 14 PRINCIPAL ACCOUNTING FEES AND SERVICES 46 PART IV 46 ITEM 15 EXHIBITS, FINANCIAL STATEMENT SCHEDULES 46 ITEM 16 FORM 10-K SUMMARY

SIGNATURES

SIGNATURES 48 i PART I ITEM 1. BUSINESS. Global Innovative Platforms Inc. f/k/a Canning Street Corporation, a Delaware corporation, ( "Global Innovative Platforms"," Canning Street," the "Company", "we," "us" or "our") is engaged in the business of testing breath to detect and assist in the treatment of disease. Our Current Business Global Innovative Platforms is focused on advancing animal health through breath analysis and air quality technology. We develop non-invasive diagnostic tools for detecting diseases, assessing treatment effectiveness, and monitoring potentially toxic environmental and food conditions. Our proprietary technologies, "VOCAM Plus" and the "FROG," utilize advanced gas chromatography and A.I. software to provide rapid and accurate breath and air analysis. The Company's mission is to revolutionize early detection of a wide array of animal related abnormalities. Applications range from disease and treatment effectiveness to potentially toxic environmental and food conditions. Early detection can save lives, money, and resources. Overview Advancements in technology have opened up numerous opportunities in the area of detecting and analyzing gasses for health related information. Various tests and devices have been developed over the years that monitor air quality and assist in the diagnosis and treatment of disease. Many diseases and conditions leave indications of their presence in the form of Volatile Organic Compounds (VOCs) that occur in various patterns we call breath prints. Equipment has evolved to capture these prints and new Machine Learning technologies (Artificial Intelligence) are able to detect such patterns using sampling. The mere existence of the VOC is of some value, but other factors such as timing, combinations with other VOCs and quantities of VOCs are also of importance. We are a medical technology company focused on applying these advancements in animals and agriculture. We have identified several opportunitie

View Full Filing

View this 10-K filing on SEC EDGAR